Parents’ and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay–Lac-St-Jean (Quebec)

A mass vaccination campaign with the 4CMenB vaccine (Bexsero®; Novartis Pharmaceutical Canada Inc) was launched in a serogroup B endemic area in Quebec. A telephone survey was conducted to assess parental and adolescent opinions about the acceptability of the vaccine. Intent to receive the vaccine o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubé, Eve, Gagnon, Dominique, Hamel, Denis, Belley, Sylvie, Gagné, Hélène, Boulianne, Nicole, Landry, Monique, Bettinger, Julie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pulsus Group Inc 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507843/
https://www.ncbi.nlm.nih.gov/pubmed/26236359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507843/
https://www.ncbi.nlm.nih.gov/pubmed/26236359

Ejemplares similares